Tremor, schizophrenia, restless legs syndrome major risk factors for incident Parkinson's disease: JAMA

Written By :  Jacinthlyn Sylvia
Medically Reviewed By :  Dr. Kamal Kant Kohli
Published On 2022-11-23 02:30 GMT   |   Update On 2022-11-23 08:12 GMT

A new study published in the Journal of American Medical Association neurology suggests that the connections reported in a representative population between Parkinson disease (PD) and specific risk factors, comorbidities, and prodromal symptoms may imply early extrastriatal and extracerebral pathology of PD.Parkinson disease's prodromal phase might extend for more than ten years. Recognizing...

Login or Register to read the full article

A new study published in the Journal of American Medical Association neurology suggests that the connections reported in a representative population between Parkinson disease (PD) and specific risk factors, comorbidities, and prodromal symptoms may imply early extrastriatal and extracerebral pathology of PD.

Parkinson disease's prodromal phase might extend for more than ten years. Recognizing the range and incidence of risk factors, comorbidities, and prodromal characteristics of Parkinson's disease can assist expand understanding of the illness's origins and progression, as well as identify persons at risk. As a result, Anette Schrag and colleagues undertook this study to determine the relationship between a subsequent PD diagnosis and a variety of risk factors and prodromal symptoms, such as lifestyle variables, comorbidities, and probable extracerebral manifestations of PD.

This was a case-control study that used outpatient consultation insurance claims from patients with German statutory health insurance between January 1, 2011, and December 31, 2020. Patients with an incident diagnosis of Parkinson's disease without a prior diagnosis of parkinsonism or dementia were matched 1:1 for age, gender, area, and earliest year of outpatient visit. Previous case-control, systematic reviews, and cohort studies reporting on risk factors, comorbidities, and prodromal symptoms of Parkinson's disease were used to determine exposures. The major goal was to code previously suggested risk factors and prodromal symptoms of Parkinson's disease (PD) using the International Statistical Classification of Diseases and Related Health Problems, Tenth Revision (ICD-10) coding.

The key findings of this study were;

1. There were 138 345 individuals with incident Parkinson's disease and 276 690 matched controls identified. Participants in the study were tracked for a mean (SD) of 6.0 (2.0) years.

2. Risk variables and prodromal characteristics linked with PD were traumatic brain injury, odds ratio (OR), 1.62; 95% CI, 1.36-1.92; alcohol abuse, OR, 1.32; 95% CI, 1.21-1.44; hypertension, OR, 1.29; 95% CI, 1.26-1.31; anosmia, OR, 2.16; 95% CI, 1.59-2.93; and parasomnias, OR, 1.62.

3. There were also links to restless legs syndrome, sleep apnea, migraine, epilepsy, bipolar illness, and schizophrenia.

4. Sensory abnormalities other than anosmia, such as hearing loss and alterations in skin feeling, have also been linked to Parkinson's disease.

5. Additionally, there were favorable correlations with gastrointestinal issues, skin issues, illnesses that could be inflammatory, and diabetes types 1 and 2. There were associations with tremor, restless legs syndrome, bipolar illness, and schizophrenia even five to ten years before the diagnosis.

In conclusion, these relationships may be caused by a genetic predisposition to PD, drug exposure, direct causation, or pathophysiologically relevant variables that contribute to the pathogenesis of PD. They may also signify potential early extrastriatal and extracerebral pathology of PD. Future investigation in prospective controlled trials is required for subtle relationships.

Reference:

Schrag, A., Bohlken, J., Dammertz, L., Teipel, S., Hermann, W., Akmatov, M. K., Bätzing, J., & Holstiege, J. (2022). Widening the Spectrum of Risk Factors, Comorbidities, and Prodromal Features of Parkinson Disease. In JAMA Neurology. American Medical Association (AMA). https://doi.org/10.1001/jamaneurol.2022.3902

Tags:    
Article Source : JAMA Neurology

Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement/treatment or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2024 Minerva Medical Treatment Pvt Ltd

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News